ロード中...
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Anlotinib is a multitargeted antiangiogenic drug, and its clinical predictor for responsive non‐small cell lung cancer (NSCLC) patients is still elusive. Here, tumor‐specific target capture is used to profile the circulating DNA of ALTER0303 (evaluating NSCLC clinical antitumor efficacy through anlo...
保存先:
| 出版年: | Adv Sci (Weinh) |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774020/ https://ncbi.nlm.nih.gov/pubmed/31592412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201900721 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|